Impact of Sleep Disorders and Digital Support on Older People's Health

NCT06944600 | Not Yet Recruiting

• 1 other identifier: 262/2024/SPER/UNIPR
• Study Type: observational
• Target: 300
• Locations: 0 countries
• Sites: N/A

Brief Summary

The goal of this observational study is to learn about the effects of sleep disorders on health and ageing in older people over the age of 65. The main question it aims to answer is: How do sleep disorders impact the motoric and cognitive ageing trajectories of older individuals? Participants will undergo a set of instrumental, laboratory and clinical diagnostic examinations to comprehensively assess the impact of sleep disorders on health.

Conditions

Sleep Disorders; Frailty; Cognitive Impairment; Quality of Life; Ageing; Digital Health; Multidisciplinary Approach

Outcome Measures

Primary Outcomes (1)

• Incidence of physical and functional worsening

  12 months

Secondary Outcomes (6)

• Prevalence and incidence of sarcopenia

  24 months

• Prevalence of mild cognitive impairment (MCI) and cognitive frailty

  24 months

• Incidence of mild cognitive impairment (MCI) and cognitive frailty

  24 months

• Incidence of dementia in cognitive frail older individuals

  24 months

• Prevalence and incidence of recognised pre-frailty conditions

  24 months

Study Arms (2)

Physically frail sarcopenic older subjects

Healthy active older subjects

Eligibility Criteria

• Age: 65 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Physically frail sarcopenic and healthy active subjects, from 65 years of age, admitted to the geriatric and sleep medicine outpatient clinic, not demented and independent in the Basic Activities of Daily Living.

You may qualify if:

• Age ≥ 65 years;
• MMSE score adjusted by age and education ≥ 25/30;
• Absence of mobility-disability;
• Absence of need for assistance with Basic Activities of Daily Living (according to the ICFSR International Clinical Practice Guidelines).

You may not qualify if:

• Individuals with specific clinical conditions that make the intervention unsafe (I.e., severe diseases, unstable health status);
• Individuals whose adherence to the protocol might be low due to clinical (E.g., cognitive impairment, dialysis) and non-clinical (E.g., plans to relocate out of the study area within the next 3 years) reasons;
• Individuals unable or unwilling to provide informed consent;
• Consumption of more than 14 alcoholic drinks per week \[one alcoholic drink (equal to 14.0 grams of pure alcohol) corresponds to 36 cc of beer (5% alcohol content), 24 cc of malt liquor (7% alcohol content), 15 cc of wine (12% alcohol content), 4.5 cc of distilled spirit or liquor (40% alcohol content)\];
• Difficulty in communicating with the study staff due to speech, language, or (non-corrected) hearing and vision problems;
• Severe arthritis (E.g., awaiting joint replacement) that would interfere with the ability to fully participate in the study;
• Lung disease requiring regular use of supplemental oxygen;
• Severe cardiovascular disease (including New York Heart Association \[NYHA\] class III or IV, clinically significant congestive heart failure and valvular disease, history of cardiac arrest, presence of an implantable defibrillator or pacemaker, uncontrolled angina);
• Upper and/or lower extremity amputation;
• Peripheral arterial disease Lériche-Fontaine 3 or 4;
• Renal disease requiring dialysis;
• Current enrolment in another study involving lifestyle, nutrition, or pharmaceutical interventions;
• Further medical, psychiatric, or behavioural factors that in the judgment of the principal investigator may interfere with the study participation;
• Further possible illnesses affecting the life expectancy and reducing it to less than 24 months, corresponding to the study's length;
• Clinical judgment concerning safety or non-compliance, as well as the conditions for which the use of the Sleep Profiler is not recommended (sensitivity of skin or scalp and/or open wounds on the forehead or scalp, allergic reactions to extended exposure to synthetic fabrics (e.g., polyester, rayon), upper respiratory infection or congestion, head circumference less than 21 or greater than 25 inches, forehead vertical measurement (from top of eyebrows to hairline) less than or equal to 2 inches or horizontal measurement (from hairline to hairline) less than or equal to 6 inches).

Sponsors & Collaborators

• University of Parma: lead

MeSH Terms

Conditions

Sleep Wake Disorders; Frailty; Cognitive Dysfunction

Condition Hierarchy (Ancestors)

Nervous System Diseases; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Mental Disorders; Pathologic Processes; Cognition Disorders; Neurocognitive Disorders

Central Study Contacts

Marcello G Maggio

CONTACT

+39 0521 703916; marcellogiuseppe.maggio@unipr.it

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: MD, PhD, Full Professor in Internal and Geriatric Medicine

Study Record Dates

• First Submitted: April 17, 2025
• First Posted: April 25, 2025
• Study Start: May 1, 2025
• Primary Completion (Estimated): November 1, 2027
• Study Completion (Estimated): November 1, 2027
• Last Updated: April 25, 2025

Record last verified: 2025-04